Therapeutic Efficacy of Categorical Language Fluency Smartphone Game Application
A Study of Therapeutic Efficacy of Categorical Language Fluency Smartphone Game Application in Mild Cognitive Impairment and Mild Alzheimer's Dementia (Baseline Study)
1 other identifier
interventional
20
0 countries
N/A
Brief Summary
The purpose of this study is to examine therapeutic efficacy of categorical language fluency smartphone game application in mild cognitive impairment and mild Alzheimer's dementia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 20, 2016
CompletedFirst Posted
Study publicly available on registry
July 28, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedMarch 25, 2020
March 1, 2020
6 months
July 20, 2016
March 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Application usage log
Log to assess compliance of participant(by describing frequency and duration of training by using application)
4-weeks treatment
Secondary Outcomes (3)
Subjective Memory Complaint Questionnaire
after 4-weeks treatment
Geriatric Depression Scale
after 4-weeks treatment
Korean version of MMSE for dementia screening
after 4-weeks treatment
Study Arms (1)
Categorical Language Fluency Smartphone Application
EXPERIMENTALSmartphone game application specifically aimed at training categorical language fluency
Interventions
4 weeks' training
Eligibility Criteria
You may qualify if:
- Aged above 55
- Confirmed literacy
- Diagnosed to mild cognitive impairment by International Working Group on Mild Cognitive Impairment and Clinical Dementia Rating(CDR) of 0 or 0.5.
- Diagnosed to possible or probable Alzheimer's dementia by NINCDS-ADRDA and Clinical Dementia Rating(CDR) of 1 or below.
You may not qualify if:
- Evidence of delirium, confusion
- Any neurological conditions causing cognitive decline such as Parkinson's disease, brain hemorrhage, brain tumor, normal pressure hydrocephalus
- Evidence of severe cerebrovascular pathology
- History of loss-of-consciousness over 1 hour due to head trauma or repetitive head trauma of mild severity
- History of substance abuse or dependence such as alcohol
- Presence of depressive symptoms that could influence cognitive function
- Presence of medical comorbidities that could result in cognitive decline
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ki Woong Kim, M.D., Ph.D.
Seoul National University Bundang Hospital, Seong-nam, Korea
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, department of neuropsychiatry
Study Record Dates
First Submitted
July 20, 2016
First Posted
July 28, 2016
Study Start
June 1, 2016
Primary Completion
December 1, 2016
Study Completion
February 1, 2017
Last Updated
March 25, 2020
Record last verified: 2020-03